£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Antidepressants for Major Depressive Disorders Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 15 days · 15 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 14 August 2026 18 August 2026 21 August 2026 25 August 2026
View at Amazon ↗

Price data last checked 76 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 15 days • 1 price levels

Days at Price
15 days 0 4 8 11 15 £520 Days at Price

Price Analysis

Most common price: £520 (15 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 15 days

Description

This comprehensive study provides a detailed outlook for the antidepressant market regarding major depressive disorders in the United States from 2023 to 2028. It focuses on latent demand, also known as potential industry earnings (P.I.E.), expressed in millions of U.S. dollars. The data covers approximately 12,600 cities across the country, offering a granular view of market opportunities. By providing the percent share each city holds relative to its state and the entire United States, this report serves as a vital resource for comparative benchmarking. These statistics assist professionals in developing effective distribution and sales force strategies based on localized demand. This report is an essential tool for understanding market potential at the city and state levels.

Key Features

The study provides latent demand estimates for antidepressants in millions of U.S. dollars across the United States.

Data includes potential industry earnings (P.I.E.) estimates for approximately 12,600 cities.

Comparative benchmarks report the percent share of each city relative to its state and the entire United States.

The report covers the market outlook for major depressive disorders for the years 2023-2028.

Statistical insights are designed to support the development of distribution and sales force strategies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China
99% match

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China

£495.00 20 Oct 2026
The 2026-2031 World Outlook for Antidepressant Drugs
99% match

The 2026-2031 World Outlook for Antidepressant Drugs

£885.00 01 Nov 2026
The 2021-2026 World Outlook for Antidepressants
99% match

The 2021-2026 World Outlook for Antidepressants

£795.00 29 Oct 2026
The 2026-2031 World Outlook for Antidepressants
99% match

The 2026-2031 World Outlook for Antidepressants

£885.00 01 Nov 2026
The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan
99% match

The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan

£595.00 10 Sep 2026
The 2026-2031 World Outlook for Antidepressant Pharmaceuticals
99% match

The 2026-2031 World Outlook for Antidepressant Pharmaceuticals

£885.00 26 Sep 2026
US Antidepressants for Anxiety Disorders Outlook 2023-2028
98% match

US Antidepressants for Anxiety Disorders Outlook 2023-2028

£520.00 25 Aug 2026
Antidepressants for Major Depressive Disorders Outlook 2023-2028
98% match

Antidepressants for Major Depressive Disorders Outlook 2023-2028

£490.00 20 Oct 2026
The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics
98% match

The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics

Price unavailable
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
98% match

The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs

£885.00 02 Nov 2026
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
98% match

The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders

£885.00 04 Nov 2026
US Anxiety and Depression Treatment Outlook 2023-2028 Study
98% match

US Anxiety and Depression Treatment Outlook 2023-2028 Study

£520.00 08 Nov 2026
The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders
97% match

The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders

£885.00 31 Oct 2026
Anxiety and Depression Outlook 2023-2028 - ICON Group
97% match

Anxiety and Depression Outlook 2023-2028 - ICON Group

£520.00 06 Nov 2026
Antidepressants: Perspectives, Medical Uses & Health Implications (Pharmacology - Research, Safety Testing and Regualtion)
97% match

Antidepressants: Perspectives, Medical Uses & Health Implications (Pharmacology - Research, Safety Testing and Regualtion)

£100.99 22 Sep 2026
Diagnostik und Verlauf depressiver Störungen: Differenzierung der Depression - Einbezug von Persönlichkeit und Temperament - multidimensionale Diagnostik
97% match

Diagnostik und Verlauf depressiver Störungen: Differenzierung der Depression - Einbezug von Persönlichkeit und Temperament - multidimensionale Diagnostik

£88.00 07 Sep 2026
Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation
97% match

Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation

Elsevier

£135.69 23 Sep 2026
Anxiety Disorder Therapeutics Outlook 2023-2028 - US Study
97% match

Anxiety Disorder Therapeutics Outlook 2023-2028 - US Study

£520.00 08 Nov 2026
Recent Advances in Depression: Complications, Awareness, and Management: (Mental Illnesses and Treatments Series)
97% match

Recent Advances in Depression: Complications, Awareness, and Management: (Mental Illnesses and Treatments Series)

Nova

Price unavailable
Prevention and Early Treatment of Depression Through the Life Course (Depression and Personality)
97% match

Prevention and Early Treatment of Depression Through the Life Course (Depression and Personality)

Springer

£43.96 26 Sep 2026
Reflections on Depression: The Lived Experiences of People with a History of Depression
96% match

Reflections on Depression: The Lived Experiences of People with a History of Depression

LAP Lambert Academic Publishing

£71.00 23 Sep 2026
Humana Translational Research Methods for MDD - Neuromethods 179
96% match

Humana Translational Research Methods for MDD - Neuromethods 179

Humana

£170.00 27 Aug 2026
Recent Advances and Challenges in the Treatment of Major Depressive Disorder: 1456 (Advances in Experimental Medicine and Biology, 1456)
96% match

Recent Advances and Challenges in the Treatment of Major Depressive Disorder: 1456 (Advances in Experimental Medicine and Biology, 1456)

Springer

£128.60 03 Sep 2026
Understanding Depression: Volume 2. Clinical Manifestations, Diagnosis and Treatment
96% match

Understanding Depression: Volume 2. Clinical Manifestations, Diagnosis and Treatment

Springer

£149.99 25 Sep 2026